UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency PR Newswire TAIZHOU, China, Dec. 16, 2021...
China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection PR Newswire TAIZHOU...
As filed with the Securities and Exchange Commission on August 27, 2021 Registration No. 333- [●] ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 2...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For...
China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split PR Newswire TAIZHOU, China, Feb. 19, 2021 TAIZHOU,Β China, Feb. 19, 2021...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:February 10,
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Und...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads